Comments on: Kutki: The Liver Herb Western Medicine Is Finally Studying

By: Brian Cooper

Brian Cooper — Thu, 11 Jun 2026 17:00:07 +0000

For anyone interested in trying Kutki, checking for CITES documentation and cultivated sources seems essential.

Mark Bennett — Wed, 03 Jun 2026 13:29:39 +0000

It’s good to see the article stressing that preclinical findings don’t replace standard liver disease care.

Kevin Martin — Mon, 25 May 2026 15:46:14 +0000

The 1996 hepatitis study’s dosage of 375 mg three times daily feels quite specific for a short term experiment.

Rebecca Turner — Sun, 17 May 2026 12:13:05 +0000

If the Phase III trial for picroliv shows positive results, could that shift how practitioners view Kutki in NAFLD?

Emily Foster — Fri, 08 May 2026 19:33:28 +0000

Seeing the reference to Ārogyavardhinī Guṭikā reminded me that many classical formulas contain multiple ingredients.

Matthew Green — Thu, 30 Apr 2026 11:18:55 +0000

The laxative effect noted in the safety section seems worth watching for when trying higher doses.

Sarah Thompson — Tue, 21 Apr 2026 21:04:59 +0000

Learning that Kutki is listed as endangered makes me think twice about sourcing it responsibly.

Rachel Adams — Mon, 13 Apr 2026 10:11:32 +0000

The article’s comparison with milk thistle highlights why we shouldn’t assume all bitter herbs work the same way.

Laura Mitchell — Sun, 05 Apr 2026 00:55:59 +0000

The caution about mixing Kutki with prescription meds is worth noting for anyone experimenting.

Chris Morgan — Fri, 27 Mar 2026 12:41:13 +0000

Does anyone know if the 2025 zebrafish study used a specific picroside rich fraction or a whole herb extract?